BioCorRx Inc. (BICX)

0.21USD +4.48% (+0.01)

Over 1M: -23.6%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.15 0.2 0.25 0.3
3 Aug 6 Aug 11 Aug 14 Aug 19 Aug 24 Aug 27 Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q2 '21 — Revenue: 15.7K Q3 '21 — Revenue: 8.8K Q4 '21 — Revenue: 13.6K Q1 '22 — Revenue: 20.5K Q2 '22 — Revenue: 16K Q3 '22 — Revenue: 94.4K Q4 '22 — Revenue: 82.9K Q1 '23 — Revenue: 40.4K Q2 '23 — Revenue: 19.6K Q3 '23 — Revenue: 10.1K Q4 '23 — Revenue: 18.9K Q1 '24 — Revenue: 3.6K Q2 '24 — Revenue: 4K Q3 '24 — Revenue: 0 Q4 '24 — Revenue: 0 Q1 '25 — Revenue: 134.9K Q2 '25 — Revenue: 178.2K Q3 '25 — Revenue: 635.2K Q1 '26 — Revenue: 214.5K Q2 '26 — Revenue: 88K 0 150K 300K 450K 600K 750K
Q3 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q2 '25 Q2 '26
Revenue Free Cash Flow

Figures as at 2025-12-31, reported in USD. The newest fact in the filings is dated 2026-06-30, 63 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 64.8%
OE margin -360.2%
Oper. margin -614.8%
Accruals -42.2%
EBITDA margin -613.2%
FCF margin -295.4%
OCF margin -295.4%
Profit margin -396.5%
ROA -165.7%
Capex / sales —
Gross margin —
OCF / EBIT —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

3.3
EV/Sales 9.4×
EV/OE -2.6×
FCF yield -37.7%
P/C 294.3×
Div. yield —
EV/EBIT —
EV/GP —
Fwd P/E —
P/B —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales 0.0013×
RPO growth —
Segment HHI —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA -0.17
Current ratio 0.07×
Interest cover -30.5×
F-score 5.6 pts
Cash / Debt 0.017×
Quick ratio 0.065×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

10.0
Sales CAGR 4Y +101.6%
Sales/sh Y/Y +5785.5%
Sales Q/Q -53.1%
Shares change +76.7%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.